Literature DB >> 30573147

Electronic Nicotine Delivery Systems or E-cigarettes: American College of Preventive Medicine's Practice Statement.

Catherine J Livingston1, Randall J Freeman2, Victoria C Costales3, John L Westhoff4, Lee S Caplan5, Kevin M Sherin6, David W Niebuhr7.   

Abstract

INTRODUCTION: E-cigarettes or or electronic nicotine delivery systems (ENDS) have rapidly gained popularity in the U.S. Controversy exists about the safety and efficacy of ENDS. The American College of Preventive Medicine's Prevention Practice Committee undertook a consensus-based evidence review process to develop a practice statement for the American College of Preventive Medicine.
METHODS: A rapid review of the literature was performed through June 2017 to identify efficacy, patient-oriented harms, and the impact on population health.
RESULTS: On an individual level, limited evidence suggests that ENDS may be effective at reducing cigarette use among adult smokers intending to quit. There is insufficient evidence addressing potential long-term harms of ENDS, and limited evidence is available about short-term harms of ENDS and the impact of secondhand exposure. Although ENDS appear safer than combustible cigarettes, they are not without risk. Among youth there is no known benefit and significant concern for harm. On a population level, there may be significant harms associated with ENDS, particularly among youth nonsmokers. The long-term balance of potential benefits versus harms from the individual and population perspectives are unclear.
CONCLUSIONS: The American College of Preventive Medicine developed practice recommendations that include encouraging screening for ENDS use, strategies to prevent the initiation of ENDS use in nonsmokers, particularly in youth, adoption of a harm reduction model for smokers intending to quit in those who refuse or fail to quit with evidence-based smoking-cessation methods, recommendations on policy and regulatory strategies to decrease public use of ENDS and regulation of their components, and future research needs.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30573147     DOI: 10.1016/j.amepre.2018.09.010

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  7 in total

1.  Electronic cigarette use among heart failure patients: Findings from the Population Assessment of Tobacco and Health study (Wave 1: 2013-2014).

Authors:  Emily C Gathright; Wen-Chih Wu; Lori A J Scott-Sheldon
Journal:  Heart Lung       Date:  2019-12-05       Impact factor: 2.210

2.  Dual Versus Never Use of E-Cigarettes Among American Indians Who Smoke.

Authors:  Dorothy A Rhoades; Ashley L Comiford; Justin D Dvorak; Kai Ding; Leslie M Driskill; Audrea M Hopkins; Paul Spicer; Theodore L Wagener; Mark P Doescher
Journal:  Am J Prev Med       Date:  2019-08-01       Impact factor: 5.043

3.  The Effect of E-cigarette Commercials on Youth Smoking: A Prospective Study.

Authors:  James Russell Pike; Nasya Tan; Stephen Miller; Christopher Cappelli; Bin Xie; Alan W Stacy
Journal:  Am J Health Behav       Date:  2019-11-01

4.  Electronic Cigarette Use Among Youth: Understanding Unique Risks in a Vulnerable Population.

Authors:  Elisa M Trucco; Nilofar Fallah-Sohy; Sarah A Hartmann; Julie V Cristello
Journal:  Curr Addict Rep       Date:  2020-10-22

Review 5.  What are the respiratory effects of e-cigarettes?

Authors:  Jeffrey E Gotts; Sven-Eric Jordt; Rob McConnell; Robert Tarran
Journal:  BMJ       Date:  2019-09-30

6.  Beliefs and practices regarding electronic cigarettes in smoking cessation among healthcare professionals in Slovenia.

Authors:  Helena Koprivnikar; Tina Zupanič; Jerneja L Farkas
Journal:  Tob Prev Cessat       Date:  2020-01-14

7.  Short-term e-cigarette vapour exposure causes vascular oxidative stress and dysfunction: evidence for a close connection to brain damage and a key role of the phagocytic NADPH oxidase (NOX-2).

Authors:  Marin Kuntic; Matthias Oelze; Sebastian Steven; Swenja Kröller-Schön; Paul Stamm; Sanela Kalinovic; Katie Frenis; Ksenija Vujacic-Mirski; Maria Teresa Bayo Jimenez; Miroslava Kvandova; Konstantina Filippou; Ahmad Al Zuabi; Vivienne Brückl; Omar Hahad; Steffen Daub; Franco Varveri; Tommaso Gori; Regina Huesmann; Thorsten Hoffmann; Frank P Schmidt; John F Keaney; Andreas Daiber; Thomas Münzel
Journal:  Eur Heart J       Date:  2020-07-07       Impact factor: 29.983

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.